- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07950605
Personalized Gait Retraining to Support Knee Health in Older Adults (BiofeedbackRCT)
A Real-time Biofeedback Intervention for Improving Tibiofemoral Cartilage Quality in Older Adults
Participants are randomized into two groups: gait retraining and habitual walking. In the gait retraining group, an intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. Real-time visual biofeedback on a knee joint loading metric is provided during some of the training sessions to facilitate learning. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Changes in knee joint cartilage properties are assessed at 5 months.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
In this randomized controlled intervention study, participants are randomized into two groups: gait retraining and habitual walking. At baseline and five months later, participants' gait mechanics and knee joint cartilage structure and quality are assessed, and blood and urine samples and questionnaire data are collected. In addition, knee joint radiographic status is assessed at baseline. Physical activity is monitored using a thigh-worn accelerometer throughout the study.
The intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. During the first session, participants try different kinematics-based gait modifications to personalize the intervention. The modifications that reduce estimated medial tibiofemoral knee joint loading the most are selected and utilized during the following sessions. The gait retraining aims at establishing a gait pattern for each individual that reduces medial tibiofemoral joint loading while also being such that the person can utilize it in their daily living. To support learning and fine-tuning the gait pattern, real-time feedback on knee joint moments is provided during part of the training sessions. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Eight of the training sessions are conducted within four weeks, while the two remaining sessions (so-called boosters) are conducted during the following four months with the aim of supporting maintenance of the learned gait pattern.
Pre-planned additional follow-ups are planned for 12 and 24 months from baseline. Knee MRI would be conducted at these follow-up points, with implementation depending on funding.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Lauri Stenroth, PhD
- Número de teléfono: +358505649096
- Correo electrónico: lauri.stenroth@uef.fi
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age above 65 or below 75 years (in full years)
- Access to a smartphone or tablet with an Android or iOS operating system
Exclusion Criteria:
- Unable to walk for 30 minutes without stopping and without an assistive device
- Body mass index <18 or >30 kg/m2
- Pain during walking
- Diagnosed with knee osteoarthritis
- Moderate (KL Grade 3) or severe (KL Grade 4) radiographical tibiofemoral osteoarthritis based on Kellgren-Lawrence (KL) Classification of Osteoarthritis
- Diagnosed with neurological disease
- Surgery of the knee joint
- Surgery or injury to the lower limbs causing pain or affecting mobility
- Current musculoskeletal injury causing pain or affecting mobility
- Contraindication for magnetic resonance imaging
- Contraindication for walking-based exercise training (e.g., cardiovascular symptoms that increase with exercise or recommendation from a medical professional to avoid moderate exercise)
- Any other condition that, in the opinion of the investigator, makes a potential participant unfit for participation or conditions that put a potential participant at risk by participation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Gait retraining
The arm receives personalized gait retraining via treadmill walking and real-time feedback. |
Personalized gait retraining using small kinematic alterations guided by real-time feedback of knee joint loading. The training is perfomed on a treadmill. |
|
Otro: Habitual walking
The arm receives equal amount of treadmill walking without feedback or instruction to alter the gait. |
Participants receive equal amount of treadmill walking as the ones receiving gait retraining intervention. This intervention serves as the comparator for the gait retraining intervention. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Medial tibiofemoral T1ρ relaxation time
Periodo de tiempo: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Medial tibiofemoral T2 relaxation time
Periodo de tiempo: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T1ρ relaxation time
Periodo de tiempo: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T2 relaxation time
Periodo de tiempo: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Tibiofemoral loading during walking
Periodo de tiempo: Baseline and 5 months
|
Tibiofemoral loading during walking assessed using musculoskeletal simulation |
Baseline and 5 months
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Periodo de tiempo: Baseline and 5 months
|
The score range is from 0 to 100. 0 represents extreme problems / worst possible knee symptoms. 100 represents no problems / perfect knee health. |
Baseline and 5 months
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
High-sensitivity C-reactive protein (hs-CRP)
Periodo de tiempo: Baseline and 5 months
|
hs-CRP (mg/L) is measured from blood samples using a particle-enhanced immunoturbidimetric assay as a marker of systemic inflammation. |
Baseline and 5 months
|
|
Glycated hemoglobin (HbA1c)
Periodo de tiempo: Baseline and 5 months
|
HbA1c (mmol/mol) is measured from blood samples using turbidimetric inhibition immunoassay as a marker of long-term blood glucose control. |
Baseline and 5 months
|
|
Knee cartilage recovery rate after loading assessed from magnetic resonance images
Periodo de tiempo: Baseline and 5 months
|
The knee joint is loaded with 20 minutes of standing and followed by repeated magnetic resonance imaging. Cartilage is segmented from the images, and the temporal recovery of the cartilage thickness in the medial tibiofemoral joint is quantified. The unit is mm/min. |
Baseline and 5 months
|
|
Proteomic analysis of serum samples
Periodo de tiempo: Baseline and 5 months
|
Liquid chromatography-mass spectrometry is used to run non-targeted peptide analysis of serum proteins. This is a pre-planned exploratory analysis that identifies hundreds of proteins and their concentration in the sample. |
Baseline and 5 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Lauri Stenroth, PhD, University of Eastern Finland
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 125/2025
- 363854 (Otro número de subvención/financiamiento: Research Council of Finland)
- FIMEA/2025/007528-5 (Otro identificador: Finnish Medicines Agency)
- 125/2025 (Otro identificador: The Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
IPD used in the publications is planned to be shared.
Marco de tiempo para compartir IPD
At the time of publication with no end date.
Criterios de acceso compartido de IPD
Open access to the IPD and supporting information to be used in scientific research. If possible, the data is made available at the time of publishing the results with link to the data repository at the publication.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .